These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 20483479)
1. Analysis of association between the catechol-O-methyltransferase (COMT) gene and negative symptoms in chronic schizophrenia. Wang Y; Fang Y; Shen Y; Xu Q Psychiatry Res; 2010 Sep; 179(2):147-50. PubMed ID: 20483479 [TBL] [Abstract][Full Text] [Related]
2. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment. Molero P; Ortuño F; Zalacain M; Patiño-García A Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961 [TBL] [Abstract][Full Text] [Related]
3. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study. Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207 [TBL] [Abstract][Full Text] [Related]
4. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Chen X; Wang X; O'Neill AF; Walsh D; Kendler KS Mol Psychiatry; 2004 Oct; 9(10):962-7. PubMed ID: 15124004 [TBL] [Abstract][Full Text] [Related]
5. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Ohnishi T; Hashimoto R; Mori T; Nemoto K; Moriguchi Y; Iida H; Noguchi H; Nakabayashi T; Hori H; Ohmori M; Tsukue R; Anami K; Hirabayashi N; Harada S; Arima K; Saitoh O; Kunugi H Brain; 2006 Feb; 129(Pt 2):399-410. PubMed ID: 16330500 [TBL] [Abstract][Full Text] [Related]
6. COMT haplotype analyses in Malaysians with schizophrenia. Tee SF; Tang PY; Loh HC Psychiatry Res; 2012 Jan; 195(1-2):83-4. PubMed ID: 21872942 [TBL] [Abstract][Full Text] [Related]
7. Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: preliminary results. Zinkstok J; van Nimwegen L; van Amelsvoort T; de Haan L; Yusuf MA; Baas F; Linszen D Psychiatry Res; 2008 Jan; 157(1-3):1-8. PubMed ID: 17850881 [TBL] [Abstract][Full Text] [Related]
8. No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population. Nunokawa A; Watanabe Y; Muratake T; Kaneko N; Koizumi M; Someya T Neurosci Res; 2007 Jul; 58(3):291-6. PubMed ID: 17482701 [TBL] [Abstract][Full Text] [Related]
9. Evidence of epistasis between the catechol-O-methyltransferase and aldehyde dehydrogenase 3B1 genes in paranoid schizophrenia. Wang Y; Hu Y; Fang Y; Zhang K; Yang H; Ma J; Xu Q; Shen Y Biol Psychiatry; 2009 Jun; 65(12):1048-54. PubMed ID: 19159868 [TBL] [Abstract][Full Text] [Related]
10. Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology. Boot E; Booij J; Abeling N; Meijer J; da Silva Alves F; Zinkstok J; Baas F; Linszen D; van Amelsvoort T J Psychopharmacol; 2011 Jul; 25(7):888-95. PubMed ID: 21447540 [TBL] [Abstract][Full Text] [Related]
11. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment. Gupta M; Bhatnagar P; Grover S; Kaur H; Baghel R; Bhasin Y; Chauhan C; Verma B; Manduva V; Mukherjee O; Purushottam M; Sharma A; Jain S; Brahmachari SK; Kukreti R Pharmacogenomics; 2009 Mar; 10(3):385-97. PubMed ID: 19290789 [TBL] [Abstract][Full Text] [Related]
12. Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia. Strous RD; Lapidus R; Viglin D; Kotler M; Lachman HM Neurosci Lett; 2006 Jan; 393(2-3):170-3. PubMed ID: 16233957 [TBL] [Abstract][Full Text] [Related]
13. Catechol-O-methyltransferase genotype is associated with plasma total homocysteine levels and may increase venous thrombosis risk. Gellekink H; Muntjewerff JW; Vermeulen SH; Hermus AR; Blom HJ; den Heijer M Thromb Haemost; 2007 Dec; 98(6):1226-31. PubMed ID: 18064318 [TBL] [Abstract][Full Text] [Related]
14. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia. Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ; J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819 [TBL] [Abstract][Full Text] [Related]
15. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia. Zinkstok J; Schmitz N; van Amelsvoort T; Moeton M; Baas F; Linszen D Genes Brain Behav; 2008 Feb; 7(1):61-9. PubMed ID: 17504246 [TBL] [Abstract][Full Text] [Related]
17. Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease. Borroni B; Grassi M; Costanzi C; Zanetti M; Archetti S; Franzoni S; Caimi L; Padovani A Neurobiol Aging; 2007 Aug; 28(8):1231-8. PubMed ID: 16837108 [TBL] [Abstract][Full Text] [Related]
18. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups. Minzenberg MJ; Xu K; Mitropoulou V; Harvey PD; Finch T; Flory JD; New AS; Goldman D; Siever LJ Psychiatr Genet; 2006 Jun; 16(3):117-24. PubMed ID: 16691129 [TBL] [Abstract][Full Text] [Related]
19. Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: new data and meta-analysis. Costas J; Sanjuán J; Ramos-Ríos R; Paz E; Agra S; Ivorra JL; Páramo M; Brenlla J; Arrojo M J Psychiatr Res; 2011 Jan; 45(1):7-14. PubMed ID: 20488458 [TBL] [Abstract][Full Text] [Related]
20. Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia. Tsai SJ; Hong CJ; Liao DL; Lai IC; Liou YJ Neuropsychobiology; 2004; 49(4):196-200. PubMed ID: 15118357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]